drugset / Trial / NCT04153253

Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage

NCT04153253

Phase 4 Completed 34 enrolled Al Hadi Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective study comparing efficacy and safety of intravitreal aflibercept injection and panretinal photocoagulation to early vitrectomy for patients with diabetic vitreous hemorrhage.

Timeline

Start
2018-03-07
Primary completion
2019-07-22
Completion
2019-09-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aflibercept Protein / enzyme biologic 2 mg Intravitreal